PMID: 3744945Jul 1, 1986Paper

SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells

International Journal of Radiation Oncology, Biology, Physics
E M ZemanW W Lee

Abstract

We have examined the effects of the benzotriazine di-N-oxide SR-4233 (3-amino-1,2,4-benzotriazine-1,4 dioxide) on a variety of aerobic and hypoxic cells in culture, and on tumors in mice. The cell lines used were Chinese hamster ovary (HA-1), mouse 10T1/2, RIF-1, and SCC VII cells, and the human cell lines HCT-8, AG1522, and A549. The effect of SR 4233 in combination with irradiation was also examined in the SCC VII tumor growing in the flank of C3H mice using clonogenic assay (tumors excised 24 hr after irradiation). We found SR-4233 to be a potent and selective killer of hypoxic cells. Cell killing as a function of time for the various cell lines was exponential, with no shoulder. Drug concentrations producing equivalent levels of cell killing were 75-200 fold lower in hypoxic than in aerobic cells for the mouse and hamster lines, and 15-50 fold lower for the human cells. In vivo experiments showed that the non-toxic dose of 0.3 mmole/kg of SR-4233 enhanced radiation-induced tumor cell kill when the drug was given between 1 hr before and 2 hr after the radiation dose. We have also shown that the drug metabolizes more rapidly under hypoxic than aerobic conditions, both in vitro and in vivo. The toxic product(s) is unknown, but...Continue Reading

References

May 1, 1978·Antimicrobial Agents and Chemotherapy·W SuterF Knüsel
Sep 1, 1979·International Journal of Radiation Oncology, Biology, Physics·S Rockwell, K A Kennedy
Dec 1, 1972·Journal of Medicinal Chemistry·A J LinA C Sartorelli
Aug 1, 1984·International Journal of Radiation Oncology, Biology, Physics·J M Brown, N Y Yu
Jan 1, 1980·Biochemical Pharmacology·K A KennedyA C Sartorelli

❮ Previous
Next ❯

Citations

Jun 1, 1993·Cancer Metastasis Reviews·P Workman, I J Stratford
Jun 1, 1993·Cancer Metastasis Reviews·A M RauthB L Kuehl
Apr 15, 1992·Biochemical Pharmacology·R J Riley, P Workman
Jan 1, 1989·Pharmacology & Therapeutics·D L Kirkpatrick
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·N RobertsonI J Stratford
Nov 1, 1996·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S Stern, M Guichard
Jan 7, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·D T YappS Lehnert
Jun 1, 1997·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·F A Shepherd
Nov 7, 1998·International Journal of Radiation Oncology, Biology, Physics·K O HicksW R Wilson
Dec 9, 1998·International Journal of Radiation Oncology, Biology, Physics·A M RauthV Misra
Apr 13, 2000·International Journal of Radiation Oncology, Biology, Physics·L N ShulmanC N Coleman
Oct 18, 2000·Critical Reviews in Oncology/hematology·G Fracasso, M Colombatti
Mar 31, 2000·Molecular Medicine Today·J M Brown
Mar 7, 2012·Chemical Research in Toxicology·Jian YinKent S Gates
Jun 2, 2004·Nature Reviews. Cancer·J Martin Brown, William R Wilson
Sep 3, 2004·Nature Reviews. Cancer·Jacques BernierAmato Giaccia
Nov 7, 2008·Nature Reviews. Cancer·Jessica A BertoutM Celeste Simon
Jul 31, 2013·Proceedings of the National Academy of Sciences of the United States of America·Abdelghani MazouziAlexander A Ishchenko
Sep 27, 2007·Journal of the National Cancer Institute·Olivier TrédanIan F Tannock
Jul 19, 2001·Anti-cancer Drugs·P M HoffR Pazdur
Mar 20, 2013·BioMed Research International·Michio YoshimuraMasahiro Hiraoka
Nov 19, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rob A CairnsNicholas C Denko
Dec 2, 2011·BMC Cancer·Kevin L Bennewith, Shoukat Dedhar
Sep 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip C MackUNKNOWN SWOG
Jul 13, 2013·Chinese Journal of Cancer·Christopher P GuiseKe Ding

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
E M ZemanJ M Brown
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
M ConzelmannM R Berger
© 2021 Meta ULC. All rights reserved